E-55888 is a drug developed by Esteve, which acts as a potent and selective full agonist at the 5HT7 serotonin receptor, and is used for investigating the role of 5-HT7 receptors in the perception of pain. When administered by itself, E-55888 is anti-hyperalgesic but not analgesic, but when administered alongside morphine, E-55888 was found to significantly increase the analgesic effects.[1][2]
Identifiers | |
---|---|
| |
ChemSpider |
|
Chemical and physical data | |
Formula | C16H23N3 |
Molar mass | 257.381 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |